Karine Fauria

Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation

Affiliated withPasqual Maragall Foundation

Research Area

Biography

Karine Fauria has not added Biography.
If you are Karine Fauria and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2021

Other Publications

Article	Year
Clinical observational research on Alzheimer's disease: what clinical trial registries can tell. Journal of Alzheimer's disease : JAD\| PubMed ID: 23186984	2013
Reference Data of the Spanish Memory Binding Test in a Midlife Population from the ALFA STUDY (Alzheimer's and Family). Journal of Alzheimer's disease : JAD\| PubMed ID: 26402091	2015
Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity. Journal of Alzheimer's disease : JAD\| PubMed ID: 26836167	2016
The Memory Binding Test: Development of Two Alternate Forms into Spanish and Catalan. Journal of Alzheimer's disease : JAD\| PubMed ID: 27060959	2016
Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort. Alzheimer's & dementia (Amsterdam, Netherlands)\| PubMed ID: 27752537	2016
Incidental findings on brain MRI of cognitively normal first-degree descendants of patients with Alzheimer's disease: a cross-sectional analysis from the ALFA (Alzheimer and Families) projec... BMJ open\| PubMed ID: 28341686	2017
Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism\| PubMed ID: 28492093	2018
The ALFA project: A research platform to identify early pathophysiological features of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.)\| PubMed ID: 29067295	2016
Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association\| PubMed ID: 29605385	2018
At, with and beyond risk: expectations of living with the possibility of future dementia. Sociology of health & illness\| PubMed ID: 29659032	2018
Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort. Alzheimer's research & therapy\| PubMed ID: 30678723	2019
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers. Alzheimer's research & therapy\| PubMed ID: 30902090	2019
APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals. NeuroImage. Clinical\| PubMed ID: 30991302	2019
Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals. Brain imaging and behavior\| PubMed ID: 31278650	2020
White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants. Human brain mapping\| PubMed ID: 31778002	2020
Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation. Brain : a journal of neurology\| PubMed ID: 32091109	2020
Impact of urban environmental exposures on cognitive performance and brain structure of healthy individuals at risk for Alzheimer's dementia. Environment international\| PubMed ID: 32151419	2020
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum. Alzheimer's & dementia : the journal of the Alzheimer's Association\| PubMed ID: 32573951	2020
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected. EMBO molecular medicine\| PubMed ID: 33169916	2020
Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease. Journal of Alzheimer's disease : JAD\| PubMed ID: 33386809	2021
Cerebral amyloid-β load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuum. Alzheimer's & dementia : the journal of the Alzheimer's Association\| PubMed ID: 33663013	2021
DHA intake relates to better cerebrovascular and neurodegeneration neuroimaging phenotypes in middle-aged adults at increased genetic risk of Alzheimer disease. The American journal of clinical nutrition\| PubMed ID: 33733657	2021
Prevention of cognitive decline in subjective cognitive decline APOE ε4 carriers after EGCG and a multimodal intervention (PENSA): Study design. Alzheimer's & dementia (New York, N. Y.)\| PubMed ID: 33816762	2021
Amyloid-β positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume. Neurobiology of aging\| PubMed ID: 33962331	2021
Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration. Alzheimer's & dementia (Amsterdam, Netherlands)\| PubMed ID: 34124336	2021
Brain correlates of urban environmental exposures in cognitively unimpaired individuals at increased risk for Alzheimer's disease: A study on Barcelona's population. Alzheimer's & dementia (Amsterdam, Netherlands)\| PubMed ID: 34258378	2021
Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile. Alzheimer's research & therapy\| PubMed ID: 34315519	2021
Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals. Environment international\| PubMed ID: 34537521	2021